New Key Statistics Module, Z-Score and F-Score
LUX:FARMX Key Ratios
Market Cap $ M | 2.45 |
Enterprise Value $ M | 8.73 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 1.00 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -- |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -- |
EV-to-EBITDA | -- |
PEG | -- |
Shares Outstanding M | 16.33 |
Net Margin (%) | -49.11 |
Operating Margin % | -49.11 |
Pre-tax Margin (%) | -49.11 |
Quick Ratio | 0.19 |
Current Ratio | 0.20 |
ROA % (ttm) | -20.43 |
ROE % (ttm) | -- |
ROIC % (ttm) | -21.66 |
Dividend Yield % | -- |
Altman Z-Score | -1.38 |
LUX:FARMX Number of Guru Trades
LUX:FARMX Volume of Guru Trades
Gurus Latest Trades with LUX:FARMX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
LUX:FARMX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data